HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Sales & Earnings Switzerland Europe

Galenica Outpaces Swiss OTC Market Growth In First Half

  • News

Executive Summary

Galenica's Verfora grows its share of the Swiss consumer health market to 10.2% as its sales jump by 14.1% in the opening six months of 2023.

You may also be interested in...



Galenica Expands Consumer Offering With Deal For Herbals Specialist Padma

Switerland's Galenica has bolstered its OTC offering by acquiring local player Padma and its portfolio of OTCs and supplements inspired by Tibetan medicine.

Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement

Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.

Pierre Fabre Takes Stake In French Women's Health Start-Up

France's Pierre Fabre is enhancing its presence in the women's health market by taking a stake in dietary supplements and cosmetics firm MiYé.

Table

View full table

Topics

Tags:
Sales & Earnings Switzerland Europe
Latest Headlines

Arcaea Resurrects Extinct Flowers With First Fragrances Under Future Society Brand; Cosmetics News

Message Clear For Xylitol Nasal Spray Firm Xlear: ‘Capitalize’ On FDA’s Oral Phenylephrine Doubts

Why Are UK CBD Brands Pivoting Into Functional Mushroom Supplements?

Haleon Helps Pharmacists #ListentoPain As Social Stigma And Isolation Increases

See All
UsernamePublicRestriction

Register

RS153918

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By